SAB Biotherapeutics (SABSW) Q4 2025 Earnings

Nov 13Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.19
-0.86
-0.54
-0.21

Details

Expected EPS
-0.458333
Actual EPS
-0.21
Surprise EPS
0.25
Surprise Percent
+54.18%

Description

⁨SAB Biotherapeutics⁩ (⁦SABSW⁩) has reported earnings of ⁦-0.21⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts